Financials
- Market Capitalization 8.92 M
- Employee 8
- Founded N/A
- CEO N/A
- Website www.aprea.com
- Headquarter Delaware, United States
- FIGI BBG00Q6Q3K37
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4811 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.25 USD | -3.85% | +4.17% | -57.63% | -51.47% | 10.26 M USD | ||
| 4829 | CRIS Curis, Inc. - Common Stock | 4.75 USD | -4.23% | -18.80% | +979.55% | +154.01% | 9.26 M USD | ||
| 4845 | BRTX BioRestorative Therapies, Inc. - Common Stock | 0.34 USD | -2.86% | -10.53% | -5.56% | -78.62% | 8.66 M USD | ||
| 4851 | QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 4.23 USD | -4.94% | -7.24% | -2.53% | -54.61% | 8.50 M USD |
Frequently asked questions about Aprea Therapeutics, Inc. - Common Stock
What is the Aprea Therapeutics, Inc. - Common Stock stock price today?
The current price of Aprea Therapeutics, Inc. - Common Stock (APRE) is 0.72. Over the past 24 hours, the stock has changed by -1.37%. Follow the APRE chart for real-time price dynamics.
What is the stock ticker of Aprea Therapeutics, Inc. - Common Stock?
Aprea Therapeutics, Inc. - Common Stock trades under the ticker APRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aprea Therapeutics, Inc. - Common Stock stock going up?
APRE has changed by -4.00% over the last week, +4.35% over the last month, and -56.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Aprea Therapeutics, Inc. - Common Stock net income for the last quarter?
Aprea Therapeutics, Inc. - Common Stock reported net income of -3.29 M for the last quarter. The previous quarter showed -2.46 M, which means net income changed by -33.89%.
How many employees does Aprea Therapeutics, Inc. - Common Stock have?
As of the latest available data, Aprea Therapeutics, Inc. - Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aprea Therapeutics, Inc. - Common Stock EBITDA?
Aprea Therapeutics, Inc. - Common Stock EBITDA is -3.42 M, and its EBITDA margin is -44.32 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aprea Therapeutics, Inc. - Common Stock stock?
You can buy Aprea Therapeutics, Inc. - Common Stock (APRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aprea Therapeutics, Inc. - Common Stock stock?
Investing in Aprea Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the APRE chart and related analysis on metatrader.com as part of your research.